Abstract
Objective We simplified and evaluated the Kaiser Permanente inpatient risk adjustment methodology (KP method) to predict in-hospital mortality, using open-source tools to measure comorbidity and diagnosis groups, and removing troponin, which is difficult to standardize across clinical assays.
Study Design and Setting Retrospective cohort study of adult general medical inpatients at 7 hospitals in Ontario, Canada.
Results In 206,155 unique hospitalizations with 6.9% in-hospital mortality, the simplified KP method accurately predicted the risk of mortality. Bias-corrected c-statistics were 0.874 (95%CI 0.872-0.877) with troponin and 0.873 (95%CI 0.871-0.876) without troponin, and calibration was excellent for both approaches. Discrimination and calibration were similar with and without troponin for patients with heart failure and acute myocardial infarction. The Laboratory-based Acute Physiology Score (LAPS, a component of the KP method) predicted inpatient mortality on its own with and without troponin with bias-corrected c-statistics of 0.687 (95%CI 0.682-0.692) and 0.680 (95%CI 0.675-0.685), respectively. LAPS was well calibrated, except at very high scores.
Conclusion A simplification of the KP method accurately predicted in-hospital mortality risk in an external general medicine cohort. Without troponin, and using common open-source tools, the KP method can be implemented for risk adjustment in a wider range of settings.
Competing Interest Statement
Outside of this research, FR and AV are part-time employees of Ontario Health (Provincial Clinical Leads)
Funding Statement
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. Amol Verma receives salary support as the Temerty Professor of AI Research and Education in Medicine. The development of the GEMINI data platform has been supported with funding from the Canadian Cancer Society, the Canadian Frailty Network, the Canadian Institutes of Health Research, the Canadian Medical Protective Association, Green Shield Canada Foundation, the Natural Sciences and Engineering Research Council of Canada, Ontario Health, the St. Michael's Hospital Association Innovation Fund, and the University of Toronto Department of Medicine, with in-kind support from partner hospitals and Vector Institute. Funders had no role in the design, conduct or interpretation of this study.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Research ethics board approval was obtained from the University Health Network (Toronto), Sunnybrook Health Sciences Centre (Toronto) and St. Michael's Hospital (Toronto) through the integrated Clinical Trials Ontario platform, with St. Michael's Hospital as the Board of Record (CTO project ID: 1394). Research ethics board approval was also obtained from Trillium Health Partners (Mississauga; REB# 742) and Mount Sinai Hospital (Toronto; REB# 15-0075-C).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
We are unable to provide unlimited open access to GEMINI data because of data sharing agreements and research ethics board protocols with participating hospitals. However, researchers can request access to GEMINI data through an established process approved by our institutional research ethics boards. Please see full details at: https://www.geminimedicine.ca/access-data